Table 3.
Co-infections with CanineCV and other viruses.
| Viruses | Clinical cases (%) (n = 71) | 95% CI | Controls (%) (n = 19) | 95% CI |
|---|---|---|---|---|
| CanineCV | 13 (18.30) | 9.31–27.29% | 19 (100) | ND |
| Co-infections | 58 (81.69) | 72.70–90.68% | 0 | ND |
| CanineCV + CPV | 41a (57.74) | 46.25–69.22% | 0 | ND |
| CanineCV + CCoV | 9 (12.67) | 4.94–20.40% | 0 | ND |
| CanineCV + CPV + CCoV | 7a (9.85) | 2.92–16.78% | 0 | ND |
| CanineCV + CPV + CCoV + CDV | 1a,b (1.40) | 0–4.13% | 0 | ND |
ND, not determined.
a
Including one sample containing a CPV vaccinal strain.
b
The detected CDV was a vaccinal strain.